The UK is becoming increasingly notorious for its unregulated market of experimental peptides and steroids, says Professor Channa Jayasena, a leading expert in reproductive endocrinology. His stark warning follows his personal experience of treating patients who are recklessly taking these substances, which he believes could have disastrous consequences for their health.
Professor Jayasena's concerns centre around the worrying trend of online vendors marketing peptides as part of "wellness" packages, often with unsubstantiated claims. Meanwhile, anabolic steroids are being promoted to enhance physical appearance and performance. He stresses that these substances pose significant risks: steroids increase mortality risk, while peptide contamination is a pressing concern due to lax quality controls in countries like China.
A recent investigation revealed how social media platforms, such as Telegram, are being exploited by fitness influencers to peddle anabolic steroids, prescription-only medicines, and unregulated peptides. This has led to the normalisation of "enhancement practices" across various demographics, driven by dissatisfaction with body image and exposure to unrealistic online images.
Professor Jayasena believes that the regulatory landscape needs a comprehensive overhaul. He argues that current bodies, such as the MHRA, are ill-equipped to address this issue effectively due to their narrow remits. This leaves a significant gap in oversight for individuals making unsubstantiated medical claims without proper qualifications, highlighting the need for a more cohesive approach.
Parliament has taken note of these concerns, with Liberal Democrat chair Layla Moran expressing worry about tech firms' apparent lack of interest in protecting users and the perceived underfunding of agencies like the MHRA. Conservative MP Luke Evans, a former GP, has repeatedly raised the issue of image and performance-enhancing drugs in Parliament, warning about the dangers of substances with unknown effects.